These new findings demonstrate for the first time that pharmacological treatment with synthetic miR-34a mimics augments the cell-killing effect of irradiation through promoting senescence induction in human NSCLC cells via targeting Myc. The gene discussed is MYC; the disease is non-small cell lung carcinoma.